Cantabio Pharmaceuticals Inc


Symbol has changed to a new ticker symbol


By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.

Contact Information

Main Phone: +1 844 200-2826
Address: 1250 Oakmead Parkway
State: CA
City / Town: Sunnyvale
Country: US
Postal Code: 94085

Issuer Information

Exchange: OTO
CEO: Gergely Toth
Employees: 7
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A